Systems Approach to Integrating Preclinical Apolipoprotein E-Knockout Investigations Reveals Novel Etiologic Pathways and Master Atherosclerosis Network in Humans.


Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
01 2022
Historique:
pubmed: 12 11 2021
medline: 18 1 2022
entrez: 11 11 2021
Statut: ppublish

Résumé

Animal models of atherosclerosis are used extensively to interrogate molecular mechanisms in serial fashion. We tested whether a novel systems biology approach to integration of preclinical data identifies novel pathways and regulators in human disease. Approach and Results: Of 716 articles published in PRESCIANT (Preclinical Science Integration and Translation) leverages published preclinical investigations to identify high-confidence pathways, networks, and regulators of human disease.

Identifiants

pubmed: 34758633
doi: 10.1161/ATVBAHA.121.317071
pmc: PMC8887835
mid: NIHMS1776981
doi:

Substances chimiques

ApoE protein, human 0
Apoe protein, mouse 0
Apolipoproteins E 0

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

35-48

Subventions

Organisme : NCRR NIH HHS
ID : S10 RR025141
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL131977
Pays : United States
Organisme : NIGMS NIH HHS
ID : R25 GM066567
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL095590
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000445
Pays : United States

Références

Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Mol Cancer Ther. 2006 Sep;5(9):2158-64
pubmed: 16985048
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Bioinformatics. 2010 May 1;26(9):1205-10
pubmed: 20335276
J Altern Complement Med. 2019 Apr;25(4):435-440
pubmed: 30431316
J Agric Food Chem. 2003 May 21;51(11):3460-5
pubmed: 12744684
ARYA Atheroscler. 2020 Jul;16(4):153-160
pubmed: 33598035
Nature. 2017 Oct 11;550(7675):204-213
pubmed: 29022597
PLoS One. 2014 Jun 02;9(6):e98165
pubmed: 24887395
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Nat Genet. 2015 Sep;47(9):1091-8
pubmed: 26258848
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
J Immunol. 1999 Jul 15;163(2):963-9
pubmed: 10395693
Neoplasia. 2001 Sep-Oct;3(5):428-36
pubmed: 11687954
J Clin Pharm Ther. 2017 Feb;42(1):27-38
pubmed: 28019014
FASEB J. 2001 Jul;15(9):1622-4
pubmed: 11427506
Cell. 1992 Oct 16;71(2):343-53
pubmed: 1423598
Toxicol Appl Pharmacol. 2014 Jan 1;274(1):24-34
pubmed: 24176876
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4471-5
pubmed: 1584779
Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):1957-62
pubmed: 21849705
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):e131-e157
pubmed: 28729366
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Science. 2020 Sep 11;369(6509):1318-1330
pubmed: 32913098
Bioinformatics. 2014 Aug 15;30(16):2375-6
pubmed: 24733291
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Biochem Med (Zagreb). 2017 Oct 15;27(3):030201
pubmed: 29180912
Nat Genet. 2020 Nov;52(11):1239-1246
pubmed: 33020666
J Res Med Sci. 2016 Nov 07;21:116
pubmed: 28255324
Age (Omaha). 1997 Jul;20(3):165-8
pubmed: 23604308
Clin Pharmacol Ther. 2008 Sep;84(3):362-9
pubmed: 18500243
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):260-8
pubmed: 19926832
Nat Genet. 2019 Mar;51(3):568-576
pubmed: 30804563
Circulation. 2002 Apr 16;105(15):1816-23
pubmed: 11956125
Science. 1992 Oct 16;258(5081):468-71
pubmed: 1411543
N Engl J Med. 2005 Mar 17;352(11):1092-102
pubmed: 15713943
Eur J Clin Pharmacol. 2013 Feb;69(2):133-41
pubmed: 22732767
BMJ. 2011 Jan 11;342:c7086
pubmed: 21224324

Auteurs

Megan M Shuey (MM)

Department of Medicine (M.M.S., J.R., Q.S.W., J.A.B.), Vanderbilt University Medical Center, Nashville, TN.

Rachel R Xiang (RR)

Molecular Cardiology Research Institute (R.R.X., M.E.M., B.V.C., Y.W., N.C., A.S., I.Z.J.), Tufts Medical Center, Boston, MA.

M Elizabeth Moss (ME)

Molecular Cardiology Research Institute (R.R.X., M.E.M., B.V.C., Y.W., N.C., A.S., I.Z.J.), Tufts Medical Center, Boston, MA.

Brigett V Carvajal (BV)

Molecular Cardiology Research Institute (R.R.X., M.E.M., B.V.C., Y.W., N.C., A.S., I.Z.J.), Tufts Medical Center, Boston, MA.

Yihua Wang (Y)

Molecular Cardiology Research Institute (R.R.X., M.E.M., B.V.C., Y.W., N.C., A.S., I.Z.J.), Tufts Medical Center, Boston, MA.

Nicholas Camarda (N)

Molecular Cardiology Research Institute (R.R.X., M.E.M., B.V.C., Y.W., N.C., A.S., I.Z.J.), Tufts Medical Center, Boston, MA.

Daniel Fabbri (D)

Department of Biomedical Informatics (D.F., P.R.), Vanderbilt University Medical Center, Nashville, TN.

Protiva Rahman (P)

Department of Biomedical Informatics (D.F., P.R.), Vanderbilt University Medical Center, Nashville, TN.

Jacob Ramsey (J)

Department of Medicine (M.M.S., J.R., Q.S.W., J.A.B.), Vanderbilt University Medical Center, Nashville, TN.

Alec Stepanian (A)

Molecular Cardiology Research Institute (R.R.X., M.E.M., B.V.C., Y.W., N.C., A.S., I.Z.J.), Tufts Medical Center, Boston, MA.

Paola Sebastiani (P)

Institute for Clinical Research and Health Policy Studies (P.S.), Tufts Medical Center, Boston, MA.

Quinn S Wells (QS)

Department of Medicine (M.M.S., J.R., Q.S.W., J.A.B.), Vanderbilt University Medical Center, Nashville, TN.

Joshua A Beckman (JA)

Department of Medicine (M.M.S., J.R., Q.S.W., J.A.B.), Vanderbilt University Medical Center, Nashville, TN.

Iris Z Jaffe (IZ)

Molecular Cardiology Research Institute (R.R.X., M.E.M., B.V.C., Y.W., N.C., A.S., I.Z.J.), Tufts Medical Center, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH